Skip to main content
Log in

Psychotropic Drug-Induced Falls in Older People

A Review of Interventions Aimed at Reducing the Problem

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Falls are a common health problem for older people, and psychotropic medications have been identified as an important independent fall risk factor. The objective of this paper was to review the literature relating to the effect of psychotropic medications on falls in older people, with a particular focus on evidence supporting minimization of their use to reduce risk of falls. A literature search identified 18 randomized trials meeting the inclusion criteria for the review of effectiveness of psychotropic medication withdrawal studies, including four with falls outcomes. One of these, which targeted reduced psychotropic medication use in the community, reported a 66% reduction in falls, while the other studies demonstrated some success in reducing psychotropic medication use but with mixed effects on falls. Other randomized trials evaluated various approaches to reducing psychotropic medications generally or specific classes of psychotropic medications (e.g. benzodiazepines), but did not report fall-related outcomes. Overall, these studies reported moderate success in reducing psychotropic medication use, and a number reported no or limited worsening of key outcomes such as sleep quality or behavioural difficulties associated with withdrawal of psychotropic medication use. Reduced prescription of psychotropic medications (e.g. seeking non-pharmacological alternatives to their use in place of prescription in the first place or, for those patients for whom these medications are deemed necessary, regular monitoring and efforts to cease use or wean off use over time) needs to be a strong focus in clinical practice for three reasons. Firstly, psychotropic medications are commonly prescribed for older people, both in the community and especially in the residential care setting, and their effectiveness in a number of clinical groups has been questioned. Secondly, there is strong evidence of an association between substantially increased risk of falls and use of a number of psychotropic medications, including benzodiazepines (particularly, the long-acting agents), antidepressants and antipsychotic drugs. Finally, the largest effect of any randomized trial of falls prevention to date was achieved with a single intervention consisting of weaning psychotropic drug users off their medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Lord S, Ward J, Williams P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health 1993; 17:240–5

    CAS  PubMed  Google Scholar 

  2. Kannus P, Parkkari J, Sievanen H, et al. Epidemiology of hip fractures. Bone 1996 Jan; 18(1 Suppl.): 57S–63S

    CAS  PubMed  Google Scholar 

  3. O’Loughlin JL, Robitaille Y, Boivin JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993 Feb 1; 137(3): 342–54

    PubMed  Google Scholar 

  4. Todd C, Skelton D. What are the main risk factors for falls among older people and what are the most effective interventions to prevent these falls? Copenhagen: World Health Organisation Regional Office for Europe (Health Evidence Network report), 2004

    Google Scholar 

  5. Campbell A, Reinken J, Allan B, et al. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981; 10(4): 264–70

    CAS  PubMed  Google Scholar 

  6. Cassell E, Clapperton A. Preventing injury in Victorian seniors aged 65 years and older. Melbourne: Monash University Accident Research Centre, Victorian Injury Surveillance Unit (VISU), 2008

    Google Scholar 

  7. Cameron I, Murray G, Gillespie L, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010 Jan 20; (1): CD005465

    Google Scholar 

  8. Gillespie L, Robertson M, Gillespie W, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009 Apr 15; (2): CD007146

    Google Scholar 

  9. Kreisfeld R, Harrison J. Hospital separations due to injury and poisoning 2005–06. Canberra (ACT): Australian Institute of Health and Welfare (AIHW), 2010

    Google Scholar 

  10. Kannus P, Niemi S, Parkkari J, et al. Epidemiology of adulthood injuries: a quickly changing injury profile in Finland. J Clin Epidemiol 2001; 54: 597–602

    CAS  PubMed  Google Scholar 

  11. Moller J. Projected costs of falls related injury to older persons due to demographic change in Australia. Report to the Commonwealth Department of Health and Ageing, under the National Falls Prevention for Older People Initiative. Canberra (ACT): Department of Communications, Information Technology and the Arts, Commonwealth of Australia, 2003

    Google Scholar 

  12. White SM, Griffiths R. Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 2011 Nov;42(11): 1230–3

    CAS  PubMed  Google Scholar 

  13. Kannus P, Niemi S, Parkkari J, et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353(9155): 802–5

    CAS  PubMed  Google Scholar 

  14. Wilson RT, Chase GA, Chrischilles EA, et al. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. Am J Public Health 2006 Jul; 96(7): 1210–8

    PubMed Central  PubMed  Google Scholar 

  15. Bentler SE, Liu L, Obrizan M, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009 Nov 15; 170(10): 1290–9

    PubMed Central  PubMed  Google Scholar 

  16. Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000 Sep; 55(9): M498–507

    CAS  PubMed  Google Scholar 

  17. Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep 2003; 1(2): 78–85

    PubMed  Google Scholar 

  18. Scheffer AC, Schuurmans MJ, van Dijk N, et al. Fear of falling: measurement strategy, prevalence, risk factors and consequences among older persons. Age Ageing 2008 Jan; 37(1): 19–24

    PubMed  Google Scholar 

  19. Murphy SL, Williams CS, Gill TM. Characteristics associated with fear of falling and activity restriction in community-living older persons. J Am Geriatr Soc 2002 Mar; 50(3): 516–20

    PubMed Central  PubMed  Google Scholar 

  20. Lord S, Sherrington C, Menz H, et al. Falls in older people: risk factors and strategies for prevention. 2nd ed. Cambridge: Cambridge University Press, 2007

    Google Scholar 

  21. Bloch F, Thibaud M, Dugué B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011; 23(2): 329–46

    PubMed  Google Scholar 

  22. Preville M, Hebert R, Boyer R, et al. Correlates of psychotropic drug use in the elderly compared to adults aged 18–64: results from the Quebec Health Survey. Aging Ment Health 2001 Aug; 5(3): 216–24

    CAS  PubMed  Google Scholar 

  23. Mann E, Kopke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 2009 May 21; 9: 18

    PubMed Central  PubMed  Google Scholar 

  24. Gobert M, D’Hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21

    PubMed  Google Scholar 

  25. Hilmer S, Mager D, Simonsick E, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7

    PubMed  Google Scholar 

  26. Psychotropic Expert Group. Therapeutic guidelines: psychotropic. Version 6. Melbourne (VIC): Therapeutic Guidelines Limited, 2008

    Google Scholar 

  27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision (DSMIV-TR). Arlington (VA): American Psychiatric Association, 2000

    Google Scholar 

  28. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med 2009 Dec 14; 169(22): 2128–39

    PubMed  Google Scholar 

  29. Jorm AF, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000 Feb; 24(1): 7–10

    CAS  PubMed  Google Scholar 

  30. Voyer P, Preville M, Cohen D, et al. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can 2010; 29(2): 205–13

    Google Scholar 

  31. Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging 2006; 23(4): 271–87

    PubMed  Google Scholar 

  32. Petrovic M, Mariman A, Warie H, et al. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 2003 Jan–Feb; 58(1): 27–36

    CAS  PubMed  Google Scholar 

  33. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010 Nov; 26(4): 583–605

    PubMed  Google Scholar 

  34. Johnsen E, Jørgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry 2008; 8: 31

    PubMed Central  PubMed  Google Scholar 

  35. Tandon R. Safety and tolerability: how do newer generation “atypical” antipsychotics compare? Psychiatr Q 2002; 73(4): 297–311

    PubMed  Google Scholar 

  36. Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005 May; 60(5): 622–6

    PubMed  Google Scholar 

  37. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44(4): 217–21

    CAS  PubMed  Google Scholar 

  38. Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009 Nov 23; 169(21): 1952–60

    PubMed  Google Scholar 

  39. Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 2010; 21(5): 658–68

    PubMed  Google Scholar 

  40. Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Cur Drug Saf 2008; 3(3): 185–9

    CAS  Google Scholar 

  41. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007 Jan 22; 167(2): 188–94

    CAS  PubMed  Google Scholar 

  42. Cumming R, Le Couteur D. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37

    CAS  PubMed  Google Scholar 

  43. van der Hooft C, Schoofs M, Ziere G, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008; 66(2): 276–82

    PubMed Central  PubMed  Google Scholar 

  44. Ginzburg R, Rosero E. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 2009; 43(1): 98–103

    PubMed  Google Scholar 

  45. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25(6): 501–19

    CAS  PubMed  Google Scholar 

  46. Wang P, Bohn R, Glynn R, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158(6): 892–8

    CAS  PubMed  Google Scholar 

  47. Wu Q, Liu J, Gallegos-Orozco J, et al. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010; 21(10): 1627–35

    CAS  PubMed  Google Scholar 

  48. Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70

    CAS  PubMed  Google Scholar 

  49. Panneman MJ, Goettsch WG, Kramarz P, et al. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 2003; 20(11): 833–9

    PubMed  Google Scholar 

  50. Kerse N, Flicker L, Pfaff JJ, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One 2008; 3(6): e2423

    PubMed Central  PubMed  Google Scholar 

  51. Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007 Jun 25; 167(12): 1240–5

    PubMed  Google Scholar 

  52. Rossi S, editor. Australian medicines handbook 2011. 11th ed. Adelaide (SA): Australian Medicines Handbook Pty. Limited, 2011

    Google Scholar 

  53. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002 Oct; 50(10): 1629–37

    PubMed  Google Scholar 

  54. Petty SJ, Hill KD, Haber NE, et al. Balance impairment in chronic antiepileptic drug users: a twin and sibling study. Epilepsia 2009; 51(2): 280–8

    PubMed  Google Scholar 

  55. Leipzig R, Cumming R, Tinetti M. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9

    CAS  PubMed  Google Scholar 

  56. Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 2009 Jul 23; 9: 30

    PubMed Central  PubMed  Google Scholar 

  57. Lord SR, Anstey KJ, Williams P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995 Mar; 39(3): 227–34

    CAS  PubMed Central  PubMed  Google Scholar 

  58. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000 Jun; 48(6): 682–5

    CAS  PubMed  Google Scholar 

  59. Golden AG, Ma Q, Nair V, et al. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother 2010; 44(9): 1369–75

    CAS  PubMed  Google Scholar 

  60. Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000 Dec; 53(12): 1222–9

    CAS  PubMed  Google Scholar 

  61. Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002 Dec; 11(8): 663–9

    CAS  PubMed  Google Scholar 

  62. Horikawa E, Matsui T, Arai H, et al. Risk of falls in Alzheimer’s disease: a prospective study. Intern Med 2005 Jul; 44(7): 717–21

    PubMed  Google Scholar 

  63. Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010; 75(14): 1263–9

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs 2010; 27(10): 815–29

    Google Scholar 

  65. Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res 2004 Aug; 16(4): 270–6

    PubMed  Google Scholar 

  66. Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument. Int Psychogeriatr 2005 Mar; 17(1): 4–12; discussion 22-9

    PubMed  Google Scholar 

  67. Campbell A, Robertson M, Gardner M, et al. Psychotropic medication withdrawal and a home based exercise program to prevent falls: a randomised controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3

    CAS  PubMed  Google Scholar 

  68. Patterson S, Hughes C, Crealey G, et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). J Am Geriatr Soc 2010; 58: 44–53

    PubMed  Google Scholar 

  69. Weber V, White A, McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008 Apr; 23(4): 399–404

    PubMed Central  PubMed  Google Scholar 

  70. Pit SW, Byles JE, Henry DA, et al. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007 Jul 2; 187(1): 23–30

    PubMed  Google Scholar 

  71. Midlöv P, Bondesson A, Eriksson T, et al. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Fam Pract 2006; 23(1): 60–4

    PubMed  Google Scholar 

  72. Findlay D, Sharma J, McEwen J, et al. Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia. Int J Geriatr Psychiatry 1989; 4: 115–20

    Google Scholar 

  73. Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med 1999; 159(15): 1733–40

    CAS  PubMed  Google Scholar 

  74. Ruths S, Straand J, Nygaard H, et al. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52(10): 1737–43

    PubMed  Google Scholar 

  75. van Reekum R, Clarke D, Conn D, et al. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. Int Psychogeriatr 2002; 14(2): 197–210

    PubMed  Google Scholar 

  76. Ten Wolde G, Dijkstra A, van Empelen P, et al. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction 2008; 103(4): 662–70

    PubMed  Google Scholar 

  77. Habraken H, Soenen K, Blondeel L, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol 1997; 51(5): 355–8

    CAS  PubMed  Google Scholar 

  78. van Eijk M, Avorn J, Porsius A, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322(7287): 654–7

    PubMed Central  PubMed  Google Scholar 

  79. Ulfvarson J, Adami J, Wredling R, et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 2003; 59(10): 735–40

    CAS  PubMed  Google Scholar 

  80. Minett T, Thomas A, Wilkinson L, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18(11): 988–93

    PubMed  Google Scholar 

  81. Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8(2): 151–7

    CAS  PubMed  Google Scholar 

  82. Rikala M, Korhonen M, Sulkava R, et al. The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. Int Psychogeriatr 2011; 23(3): 473–84

    PubMed  Google Scholar 

  83. Hill A, Hoffmann T, Hill K, et al. Measuring falls events in acute hospitals-a comparison of three reporting methods to identify missing data in the hospital reporting system. J Am Geriatr Soc 2010; 58(7): 1347–52

    PubMed  Google Scholar 

  84. Lamb S, Jørstad-Stein E, Hauer K, et al., Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53(9): 1618–22

    PubMed  Google Scholar 

  85. Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002; 50(9): 1484–91

    PubMed  Google Scholar 

  86. Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006 Nov; 35(6): 586–91

    PubMed  Google Scholar 

  87. Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64

    PubMed  Google Scholar 

  88. Nishtala P, McLachlan A, Bell J, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32

    PubMed  Google Scholar 

  89. Oude Voshaar R, Gorgels W, Mol A, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498–504

    Google Scholar 

  90. Salzman C, Nobel K, Fisher J, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7(7): 89–93

    Google Scholar 

  91. Curran H, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003; 33(7): 1223–37

    CAS  PubMed  Google Scholar 

  92. Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs 2009 Sep; 35(9): 28–38

    PubMed Central  PubMed  Google Scholar 

  93. Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian community care. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009

    Google Scholar 

  94. Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian residential aged care facilities. Canberra (ACT): Australian ACSQHC, Commonwealth of Australia, 2009

    Google Scholar 

  95. Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian hospitals. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009

    Google Scholar 

  96. National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people: guidelines commissioned by the National Institute for Clinical Excellence (NICE) [clinical guideline 21]. London: Royal College of Nursing, 2004

    Google Scholar 

  97. Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011 Jan; 59(1): 148–57

    Google Scholar 

  98. Ballard C, Gauthier S, Cummings J, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5(5): 245–55

    CAS  PubMed  Google Scholar 

  99. Hendriks G, Oude Voshaar R, Keijsers G, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2008; 117(6): 403–11

    CAS  PubMed  Google Scholar 

  100. Oude Voshaar R, Couvée J, van Balkom A, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006; 189: 213–20

    Google Scholar 

  101. National Ageing Research Institute and Melbourne Extended Care and Rehabilitation Service. Falls risk for older people–community setting (FROP-Com). Parkville (VIC): National Ageing Research Institute (NARI) [online]. Available from URL: http://www.mednwh.unimelb.edu.au/research/pdf_docs/FropCom2009/Falls-risk-for-older-people-community-setting-09.pdf [Accessed 2011 Oct 31]

  102. Russell MA, Hill KD, Blackberry I, et al. The reliability and predictive accuracy of the falls risk for older people in the community assessment (FROP-Com) tool. Age Ageing 2008 Nov; 37(6): 634–9

    PubMed  Google Scholar 

  103. Fallscreen: the falls risk calculator. Randwick (NSW): Neuroscience Research Australia [online]. Available from URL: http://www.neura.edu.au/index.php?q=FBRG/#The-physiological-assessments [Accessed 2011 Oct 31]

  104. Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003 Mar; 83(3): 237–52

    PubMed  Google Scholar 

  105. Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32

    CAS  PubMed  Google Scholar 

  106. Dahl LJ, Wright R, Xiao A, et al. Quality improvement in long term care: the psychotropic assessment tool (PAT). J Am Med Dir Assoc 2008 Nov; 9(9): 676–83

    PubMed Central  PubMed  Google Scholar 

  107. Lampe L. Antidepressants: not just for depression. Aust Prescr 2005; 28(4): 91–3

    Google Scholar 

  108. Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis. J Aging Health 2011; 23(3): 387–416

    PubMed  Google Scholar 

  109. Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2011; 72(4): 529–38

    PubMed  Google Scholar 

  110. Windle G, Hughes D, Linck P, et al. Is exercise effective in promoting mental well-being in older age? A systematic review. Aging Ment Health 2010 Aug; 14(6): 652–69

    PubMed  Google Scholar 

  111. Smith AJ, Tett SE. An intervention to improve benzodiazepine use: anew approach. Fam Pract 2010 Jun; 27(3): 320–7

    PubMed  Google Scholar 

  112. Smith AJ, Tett SE. Interventions to improve benzodiazepine prescribing, lessons from the past 20 years to guide future interventions. BMC Health Serv Res 2010; 10(1): 321

    PubMed Central  PubMed  Google Scholar 

  113. Cook JM, Marshall R, Masci C, et al. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007 Mar; 22(3): 303–7

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no conflicts to declare and have not received any funding for writing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keith D. Hill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hill, K.D., Wee, R. Psychotropic Drug-Induced Falls in Older People. Drugs Aging 29, 15–30 (2012). https://doi.org/10.2165/11598420-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11598420-000000000-00000

Keywords

Navigation